SCGB1A1 and chronic obstructive pulmonary disease: Most studies investigating the SCGB1A1 rs3741240 variant and its impact on CC16 expression have been conducted in Western populations, with minimal data available from Indian cohorts, despite India’s distinct genetic background, diverse environmental exposures, and high COPD burden.